John P. Roberts, MD, FACS

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
John P. Roberts, MD, FACS

Professor, Department of Surgery, and Chief, Division of Transplantation, UCSF

Phone: (415) 353-1888 (appts)
Box 0780, UCSF
San Francisco, CA 94143-0780

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Education

Stanford University, Palo Alto, CA, BS, 1976, Biology
University of California, San Diego, CA, MD, 1980, Medicine
University of Washington, Seattle, Surgery Resident, 1980-83
Cornell University, New York, Research Fellow, 1983-85
University of Washington, Seattle, Surgery Resident, 1985-86
University of Minnesota, Minneapolis, Transplant Fellow, 1986-87


Professional Experience

  • 1988-1993
    University of California San Francisco, Assistant Professor
  • 1993-1997
    University of California San Francisco, Associate Professor
  • 1995-present
    California Pacific Medical Center, San Francisco, Surgical Director, Liver Transplant Department
  • 1997-present
    University of California San Francisco, Professor
  • 1999-present
    University of California San Francisco, Chief, Transplant Service

Honors & Awards

  • 1991
    Chief Resident Teaching Award, Department of Surgery, UCSF
  • 1992
    Chief Resident Teaching Award, Department of Surgery, UCSF

Selected Publications

  1. Impact of a quality improvement project on deceased organ donor management. Prog Transplant. 2015 Dec; 25(4):351-60.
    View on PubMed
  2. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Liver Transpl. 2015 Nov; 21(11):1403-9.
    View on PubMed
  3. Transplantation: Allocation of liver transplants-a road to consensus. Nat Rev Gastroenterol Hepatol. 2015 Nov; 12(11):615-6.
    View on PubMed
  4. The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing. Ann Surg. 2015 Aug; 262(2):224-7.
    View on PubMed
  5. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med. 2015 Jul 30; 373(5):405-14.
    View on PubMed
  6. Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant. 2015 Jun; 29(6):506-12.
    View on PubMed
  7. Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.
    View on PubMed
  8. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation. Liver Int. 2015 Sep; 35(9):2167-73.
    View on PubMed
  9. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. Clin Transplant. 2015 Jan; 29(1):52-9.
    View on PubMed
  10. Does center-specific reporting limit innovation. Liver Transpl. 2014 Nov; 20 Suppl 2:S42-4.
    View on PubMed
  11. Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization. Am J Cardiovasc Dis. 2014; 4(3):133-9.
    View on PubMed
  12. Response to letter to the editors. Liver Transpl. 2014 Oct; 20(10):1285.
    View on PubMed
  13. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl. 2014 Aug; 20(8):945-51.
    View on PubMed
  14. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2014 Aug; 20(8):937-44.
    View on PubMed
  15. Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list. Liver Transpl. 2014 May; 20(5):627-8.
    View on PubMed
  16. Author response: reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant. 2014 Apr; 14(4):981.
    View on PubMed
  17. Left versus right lobe liver donation. Am J Transplant. 2014 Feb; 14(2):251-2.
    View on PubMed
  18. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl. 2013 Dec; 19(12):1343-53.
    View on PubMed
  19. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012. Liver Transpl. 2014 Jan; 20(1):89-99.
    View on PubMed
  20. Consumerist responses to scarcity of organs for transplant. Virtual Mentor. 2013 Nov; 15(11):966-72.
    View on PubMed

Go to UCSF Profiles, powered by CTSI